These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35998677)

  • 21. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
    Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
    Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor-deficient mice.
    Golonka RM; Yeoh BS; Saha P; Gohara A; Tummala R; Stepkowski S; Tiwari AK; Joe B; Gonzalez FJ; Gewirtz AT; Vijay-Kumar M
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37219858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway.
    Fang S; Wang T; Li Y; Xue H; Zou J; Cai J; Shi R; Wu J; Ma Y
    Int J Biol Macromol; 2022 Apr; 205():23-36. PubMed ID: 35176320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral microbiota and liver diseases.
    Elghannam MT; Hassanien MH; Ameen YA; Turky EA; Elattar GM; ElRay AA; Eltalkawy MD
    Clin Nutr ESPEN; 2023 Apr; 54():68-72. PubMed ID: 36963900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response.
    Delaune V; Orci LA; Lacotte S; Peloso A; Schrenzel J; Lazarevic V; Toso C
    Expert Opin Biol Ther; 2018 Oct; 18(10):1061-1071. PubMed ID: 30173562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).
    Benedé-Ubieto R; Cubero FJ; Nevzorova YA
    Gut Microbes; 2024; 16(1):2331460. PubMed ID: 38512763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Milieu Related to Dysbiotic Gut Microbiota Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Huang C; Mei S; Zhang X; Tian X
    J Clin Gastroenterol; 2023 Sep; 57(8):782-788. PubMed ID: 37406184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice.
    Feng D; Zhang H; Jiang X; Zou J; Li Q; Mai H; Su D; Ling W; Feng X
    Environ Pollut; 2020 Oct; 265(Pt A):114880. PubMed ID: 32540565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiome and liver cancer: mechanisms and clinical translation.
    Yu LX; Schwabe RF
    Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
    Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
    Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism.
    Jang YO; Kim OH; Kim SJ; Lee SH; Yun S; Lim SE; Yoo HJ; Shin Y; Lee SW
    Sci Rep; 2021 Mar; 11(1):7008. PubMed ID: 33772084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis.
    Zhang YL; Li ZJ; Gou HZ; Song XJ; Zhang L
    Front Cell Infect Microbiol; 2022; 12():945368. PubMed ID: 36189347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.